UNCY

Unicycive Therapeutics, Inc.

0.70 USD
+0.06 (+8.64%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Unicycive Therapeutics, Inc. stock is down -32.22% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 June’s closed higher than May. 100% of analysts rate it a buy.

About Unicycive Therapeutics, Inc.

Unicycive Therapeutics, Inc. engages in developing novel therapies for kidney diseases in the United States. The company was incorporated in 2016 and is based in Los Altos, California.

  • Benchmark
    Mon Jun 3, 11:58
    buy
    confirm
  • Benchmark
    Fri May 31, 11:07
    buy
    confirm
  • HC Wainwright & Co.
    Wed May 29, 06:43
    buy
    confirm